Cancer News and Research

Latest Cancer News and Research

New assay can identify rare cancerous cells within mixed populations

Rare cells can be identified within mixed cell populations with near perfect accuracy using a detection technique devised by research teams led by Robert Wieder, MD, PhD, at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School and Rajan Kumar, MD, PhD, at Genome Data Systems in Hamilton, N.J. This technique may facilitate cancer diagnosis, which often relies on the detection of rare cancerous cells in tiny amounts of biopsy tissue or fluid.

12 Jul 2012

Study details how resistance to targeted drug therapy emerges in colorectal cancers

A Harvard researcher studying the evolution of drug resistance in cancer is predicting that, in a few decades, "many, many cancers could be manageable."

12 Jul 2012

Prenatal and early childhood exposure to PCE may be associated with long-term visual impairments

Prenatal and early childhood exposure to the chemical solvent tetrachloroethylene (PCE) found in drinking water may be associated with long-term visual impairments, particularly in the area of color discrimination, a new study led by Boston University School of Public Health (BUSPH) researchers has found.

12 Jul 2012

NOXXON commences Spiegelmer NOX-A12 Phase IIa trial in CLL

NOXXON Pharma today announced the treatment of the first cohort of three chronic lymphocytic leukemia (CLL) patients in a Phase IIa clinical trial of its NOX-A12 anti-CXCL12/SDF-1 (CXC Chemokine Ligand 12 / Stromal Cell-Derived Factor-1) Spiegelmer.

12 Jul 2012

Dolutegravir-based regimen demonstrates superiority over Atripla in treatment-naive adults with HIV-1

Shionogi-ViiV Healthcare LLC today announced that initial results have been received from the Phase III SINGLE (ING114467) study of the investigational integrase inhibitor dolutegravir in treatment-naive adults with HIV-1.

12 Jul 2012

Secure protocol allows linking of patient records without revealing personal information

Monitoring the effectiveness of the HPV vaccine in Canada requires that data from multiple registries and other data sources be combined. Linking registries can be problematic, however, since they are often managed by unrelated organizations. Privacy legislation may also restrict the sharing of data for such linkages.

12 Jul 2012

More selective colon cancer screening urged

Updated guidance from a US task force stresses the need for targeted, high-quality follow-up screening in patients who have undergone colonoscopy or polyp removal, in an effort to cut down on unnecessary repeat procedures

11 Jul 2012

Collaboration is key to effective cancer palliation

Collaborative decision-making and frequent meetings between palliative care teams and oncology staff are the most critical factors for improving end-of-life care, say French researchers.

11 Jul 2012

Arrowhead initiates Adipotide Phase 1 trial in obesity

Arrowhead Research Corporation, a targeted therapeutics company, today announced that the first patient has been dosed in a Phase 1 clinical trial with Adipotide, a new class of treatment for obesity.

11 Jul 2012

BioInvent announces data from BI-204 phase IIa study on stable atherosclerotic vascular disease

BioInvent International AB today announced data from the GLACIER phase IIa study evaluating BI-204 in patients with stable atherosclerotic vascular disease. BioInvent is developing BI-204 in collaboration with Genentech, a member of the Roche Group.

11 Jul 2012

OncoSec establishes UCSF as second enrolling site for OMS-I110 Phase II Merkel cell carcinoma trial

OncoSec Medical Inc., a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announces it has established the University of California San Francisco (UCSF) as the second enrolling site for its Phase II Merkel cell carcinoma clinical trial (OMS-I110).

11 Jul 2012

ImmunoGen announces start of IMGN853 Phase I trial for ovarian cancer, other solid tumors

ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced the start of clinical testing with its IMGN853 product candidate.

11 Jul 2012

Roundup: Tough to get on Calif.'s new adult day care

Community-Based Adult Services began March 1 as part of a legal settlement between the state and advocates that sued over Gov. Jerry Brown's plan to eliminate Adult Day Health Care entirely.

11 Jul 2012

Chemotherapy improves survival for patients with periampullary cancer following resection

Patients who had surgery for periampullary cancer (a variety of types of cancer that are located in and near the head of the pancreas, including an area called the ampulla where the bile duct joins up with the pancreatic duct to empty their secretions into the upper small intestine) and received chemotherapy had a statistically significant survival benefit, compared to patients who did not receive chemotherapy, after adjusting for prognostic variables, according to a study in the July 11 issue of JAMA.

11 Jul 2012

Victims of stray-bullet shootings are often children, females

Most people killed or wounded in stray-bullet shootings were unaware of events leading to the gunfire that caused their injuries, and nearly one-third of the victims were children and nearly half were female, according to a new nationwide study examining an often-overlooked form of gun violence.

11 Jul 2012

Breast cancer drug bevacizumab slows progression but has no overall survival benefit

The cancer drug bevacizumab (Avastin®) offers only a modest benefit in prolonging disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers. The researchers assessed the efficacy of bevacizumab in combination with chemotherapy, an established cancer treatment in this indication, and found no overall survival benefit when adding bevacizumab to chemotherapy.

11 Jul 2012

Euthanasia and assisted suicide rates in the Netherlands comparable to rates before legalisation

2010 rates of euthanasia and assisted suicide in the Netherlands were comparable to levels before the practices were legalised in 2002, according to new research published Online First in The Lancet and conducted by a Dutch research team from Erasmus MC University Medical Centre, Rotterdam; VU University Medical Centre, Amsterdam; Statistics Netherlands, The Hague; and Utrecht’s University Medical Centre.

11 Jul 2012

Fatal outcome from HFMD is rare, says LUHS pediatric infectious disease specialist

A mysterious disease that has killed nearly 60 children in Cambodia has been identified by the World Health Organization as enterovirus 71. This virus is one among a family of viruses that cause a variety of illnesses, including a common childhood illness called hand, foot and mouth disease, but Andrew Bonwit, MD, pediatric infectious disease specialist at Loyola University Health System, says a fatal outcome from such illness is rare.

11 Jul 2012

Registration now open for Disease Models & Mechanisms' one-day symposium

Registration is now open for Disease Models & Mechanisms' one-day symposium entitled Protein-Folding Diseases: Models & Mechanisms.

11 Jul 2012

Clinical preventive services increase by IPHR

Patients who use an interactive personal health record (IPHR) are almost twice as likely to be up to date with clinical preventive services as those who do not, according to a new study led by Alex Krist, M.D., M.P.H., research member of the Cancer Prevention and Control program at Virginia Commonwealth University Massey Cancer Center.

11 Jul 2012

Cancer News and Research

Latest Cancer News and Research

New assay can identify rare cancerous cells within mixed populations

Study details how resistance to targeted drug therapy emerges in colorectal cancers

Prenatal and early childhood exposure to PCE may be associated with long-term visual impairments

NOXXON commences Spiegelmer NOX-A12 Phase IIa trial in CLL

Dolutegravir-based regimen demonstrates superiority over Atripla in treatment-naive adults with HIV-1

Secure protocol allows linking of patient records without revealing personal information

More selective colon cancer screening urged

Collaboration is key to effective cancer palliation

Arrowhead initiates Adipotide Phase 1 trial in obesity

BioInvent announces data from BI-204 phase IIa study on stable atherosclerotic vascular disease

OncoSec establishes UCSF as second enrolling site for OMS-I110 Phase II Merkel cell carcinoma trial

ImmunoGen announces start of IMGN853 Phase I trial for ovarian cancer, other solid tumors

Roundup: Tough to get on Calif.'s new adult day care

Chemotherapy improves survival for patients with periampullary cancer following resection

Victims of stray-bullet shootings are often children, females

Breast cancer drug bevacizumab slows progression but has no overall survival benefit

Euthanasia and assisted suicide rates in the Netherlands comparable to rates before legalisation

Fatal outcome from HFMD is rare, says LUHS pediatric infectious disease specialist

Registration now open for Disease Models & Mechanisms' one-day symposium

Clinical preventive services increase by IPHR

Cancer Research - Second Edition eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Newsletters you may be interested in